BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11790796)

  • 1. Cloning and characterization of a lysosomal phospholipase A2, 1-O-acylceramide synthase.
    Hiraoka M; Abe A; Shayman JA
    J Biol Chem; 2002 Mar; 277(12):10090-9. PubMed ID: 11790796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reminiscence of phospholipase B in Penicillium notatum.
    Saito K
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(9):333-46. PubMed ID: 25391318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of negatively charged lipids in lysosomal phospholipase A2 function.
    Abe A; Shayman JA
    J Lipid Res; 2009 Oct; 50(10):2027-35. PubMed ID: 19321879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis.
    Hinkovska-Galcheva V; Treadwell T; Shillingford JM; Lee A; Abe A; Tesmer JJG; Shayman JA
    J Lipid Res; 2021; 62():100089. PubMed ID: 34087196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of SPNS1 results in accumulation of lysolipids and lysosomal storage disease in mouse models.
    Ha HT; Liu S; Nguyen XT; Vo LK; Leong NC; Nguyen DT; Balamurugan S; Lim PY; Wu Y; Seong E; Nguyen TQ; Oh J; Wenk MR; Cazenave-Gassiot A; Yapici Z; Ong WY; Burmeister M; Nguyen LN
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38451736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycerophosphodiesters inhibit lysosomal phospholipid catabolism in Batten disease.
    Nyame K; Hims A; Aburous A; Laqtom NN; Dong W; Medoh UN; Heiby JC; Xiong J; Ori A; Abu-Remaileh M
    Mol Cell; 2024 Apr; 84(7):1354-1364.e9. PubMed ID: 38447580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dynamics of Gene Expression Unraveling the Immune Response of
    Peng X; Lan X; Zhong Z; Tu H; Yao X; Tang Q; Xia Z; Yang G; Yi S
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal phospholipase A2 contributes to the biosynthesis of the atypical late endosome lipid bis(monoacylglycero)phosphate.
    Chen J; Cazenave-Gassiot A; Xu Y; Piroli P; Hwang R; DeFreitas L; Chan RB; Di Paolo G; Nandakumar R; Wenk MR; Marquer C
    Commun Biol; 2023 Feb; 6(1):210. PubMed ID: 36823305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic and lipidomic profiling of demyelinating lesions identifies fatty acids as modulators in lesion recovery.
    Penkert H; Bertrand A; Tiwari V; Breimann S; Müller SA; Jordan PM; Gerl MJ; Klose C; Cantuti-Castelvetri L; Bosch-Queralt M; Levental I; Lichtenthaler SF; Werz O; Simons M
    Cell Rep; 2021 Oct; 37(4):109898. PubMed ID: 34706241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M05B5.4 (lysosomal phospholipase A2) promotes disintegration of autophagic vesicles to maintain
    Li Y; Wang X; Li M; Yang C; Wang X
    Autophagy; 2022 Mar; 18(3):595-607. PubMed ID: 34130592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin Inhibition Modulates Metabolism and Polarization of Tumor-Associated Macrophages.
    Oelschlaegel D; Weiss Sadan T; Salpeter S; Krug S; Blum G; Schmitz W; Schulze A; Michl P
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic and Proteomic Analysis of the Tentacles and Mucus of
    Ramírez-Carreto S; Vera-Estrella R; Portillo-Bobadilla T; Licea-Navarro A; Bernaldez-Sarabia J; Rudiño-Piñera E; Verleyen JJ; Rodríguez E; Rodríguez-Almazán C
    Mar Drugs; 2019 Jul; 17(8):. PubMed ID: 31349621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of Lysosomal Phospholipase A
    Bouley RA; Hinkovska-Galcheva V; Shayman JA; Tesmer JJG
    Biochemistry; 2019 Apr; 58(13):1709-1717. PubMed ID: 30830753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically Compromising Phospholipid Metabolism Limits Candida albicans' Virulence.
    Wong D; Plumb J; Talab H; Kurdi M; Pokhrel K; Oelkers P
    Mycopathologia; 2019 Apr; 184(2):213-226. PubMed ID: 30693413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role for DGATs in cancer.
    Hernández-Corbacho MJ; Obeid LM
    Adv Biol Regul; 2019 May; 72():89-101. PubMed ID: 30579761
    [No Abstract]   [Full Text] [Related]  

  • 16. Phospholipase A
    Murakami M; Yamamoto K; Taketomi Y
    Inflamm Regen; 2018; 38():31. PubMed ID: 30546811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal phospholipase A2.
    Shayman JA; Tesmer JJG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):932-940. PubMed ID: 30077006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of pH profile and acyl chain selectivity in lysosomal phospholipase A
    Hinkovska-Galcheva V; Kelly R; Manthei KA; Bouley R; Yuan W; Schwendeman A; Tesmer JJG; Shayman JA
    J Lipid Res; 2018 Jul; 59(7):1205-1218. PubMed ID: 29724779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-13 progenitor-derived hepatocytes (B-13/H cells) model lipid dysregulation in response to drugs and chemicals.
    Leitch AC; Probert PME; Shayman JA; Meyer SK; Kass GEN; Wright MC
    Toxicology; 2017 Jul; 386():120-132. PubMed ID: 28552552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.
    Yamashita A; Hayashi Y; Matsumoto N; Nemoto-Sasaki Y; Koizumi T; Inagaki Y; Oka S; Tanikawa T; Sugiura T
    Biology (Basel); 2017 Mar; 6(2):. PubMed ID: 28358327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.